Ken Fisher Cuts His Stake in Royal Bank, Buys Roche Holding

Largest trades in second quarter include also Infosys and Alibaba

Author's Avatar
Oct 12, 2015
Article's Main Image

Ken Fisher (Trades, Portfolio) is the chief executive officer and chief investment officer of Fisher Investments, which offers an array of educational resources to its 27,000-plus private clients —including quarterly reports, in-person seminars and regular phone communication. Fisher Investments extends these educational resources to the public through a series of investing guides, online videos and daily commentary at MarketMinder.com.

Fisher manages a portfolio composed of 592 stocks with a total value of $49.932 billion and the following are the largest of about 500 trades he closed during the second quarter.

He reduced his stake in Royal Bank Of Canada (RY) by 98.48% with an impact of 0.82% on his portfolio.

The company is a financial services company which provides personal and commercial banking. It has five segments; Personal & Commercial Banking, Wealth Management, Insurance, Investor & Treasury Services & Capital Markets. It provides financial products and services to individual and business clients.

RBC had a strong second quarter, with net income 14% up compared to Q2 2014 and return on common equity was 19.3% up from the same quarter of a year before.

The stock is trading with a P/E ratio of 11.30 and has been as high as $74.09 and as low as $51.27 in the past year. It is currently 22.93% below its 52-week high and 11.37% above its 52-week low. According to the DCF calculator, the company currently looks undervalued by 22%.

The company is paying a very high yield of 4.35% to its shareholders.

Jim Simons (Trades, Portfolio) is the company's leading shareholder among the gurus with 0.04% of outstanding shares, followed by Scott Black (Trades, Portfolio) and Ken Fisher (Trades, Portfolio) with an easy stake of 0.01%.

He increased his stake in Roche Holding AGÂ (RHHBY) by 409.71% with an impact of 0.80% on his portfolio.

It is a pharmaceutical and diagnostic company. It researches and produces medicines in oncology, infectious diseases, immunology and neuroscience. It has more than 66 new molecular entities in its pipeline. The company's business is organized into two divisions: Pharmaceuticals and diagnostics.

The company reported strong sales growth in the first quarter of 2015 in which group sales were up 5% at constant exchange rates and 3% in Swiss francs. Recently Roche has been awarded a five-year contract by the National Institute for Public Health and the Environment (RIVM) in the Netherlands for implementation of the cobas(rtm) HPV Test as the first line.

The stock is trading with a P/E ratio of 23.60 and according to the DCF calculator, the company currently looks overpriced by 105%.

Ken Fisher (Trades, Portfolio) is the company's leading shareholder among the gurus with 0.21% of outstanding shares, followed by Bill Frels (Trades, Portfolio) with 0.04%

He increased his stake in Bayer AG. (BAYRY) by 83.74% with an impact of 0.59% on his portfolio.

Bayer AG is an international research-based company active in life sciences, polymers, and chemicals. Bayer's operating units include health-care products, material sciences, and crop sciences. Bayer's over-the-counter health-care product division is the third largest in the world.

During the second quarter Bayer had a very good business development at Health Care in which sales of the Bayer Group moved ahead in the second quarter and were +18.2% up from Q2 2014 and EBITDA was 33.2% ahead of the prior-year period.

The stock is trading with a P/E ratio of 26.30 and has been as high as $156.77 and as low as $124.61 in the past year. It is currently 19.40% below its 52-week high and 1.40% above its 52-week low. Regardless it is trading near its 52-week low, the DCF calculator says the company is overpriced by 74%

Ken Fisher (Trades, Portfolio) is the only guru holding shares in the company with a stake of 0.56% of outstanding shares that is 1.29% of total assets.

He reduced his stake in LVMH Moet Hennessy Louis Vuitton SEÂ (LVMUY) by 42.81% with an impact of 0.42% on his portfolio.

It is an international luxury goods producer and distributor formed in 1987. The company has a portfolio of over 60 brands and an international retail network of 3,384 stores. The firm is segmented into five business units; Wine and Spirits, Fashion and Leather Goods, Perfumes and Cosmetics, Watches and Jewelry and Selective Retailing.

The world’s leading high quality products group, it reported a 16% increase for revenue and 3% increase for organic revenue compared to the first quarter in 2014.

The stock is trading with a P/E ratio of 14.80 and has been as high as $38.7100 and as low as $31.2500 in the past year. It is currently 2.74% below its 52-week high and 20.48% above its 52-week low. According to the DCF calculator, the company currently looks undervalued by 27%

Ken Fisher (Trades, Portfolio) is the only guru shareholder in the company with a stake of 0.31% of outstanding shares that is 0.55% of total assets.

He increased his stake in Infosys Ltd. (INFY) by 139.20% with an impact of 0.40% on his portfolio.

The company designs and delivers IT-enabled business solutions to its clients. It provides technology, business consulting, outsourcing and engineering services to help clients in over thirty countries.

During the second quarter driven by recent initiatives around service differentiation, improvement in client mining and higher focus on winning large deals it had strong all-round growth and the company reported a 9.8% rise in its net profit but lowered its revenue forecast for the financial year.

The stock is trading with a P/E ratio of 21.20 and has been as high as $19.40 and as low as $15.20 in the past year. It is currently 1.59% below its 52-week high and 25.95% above its 52-week low. According to the DCF calculator, the company currently looks undervalued by 19%

Ken Fisher (Trades, Portfolio) is the company's leading shareholder among the gurus with 0.95% of outstanding shares followed by Jeremy Grantham (Trades, Portfolio) with 0.11% and John Hussman (Trades, Portfolio) with 0.04% of outstanding shares.

He bought 1,306,608 shares in Alibaba Group Holding Ltd. (BABA) with an impact of 0.22% on his portfolio.

It is a holding company and conducts its businesses through its subsidiaries. It is engaged in online and mobile commerce through products, services and technology that enable businesses to operate efficiently and extend their reach to sell to consumers and businesses in the People's Republic of China (the "PRC" or "China") and internationally.

The company had a strong second quarter and had an increase of 28% year over year for revenue and Mobile GMV had an increase of 125% year-over-year. As growing its business internationally is a strategic priority for the company, in recent months it made substantial progress in providing international brands access to Chinese consumers shopping on its marketplaces.

The stock is trading with a P/E ratio of 25.70 and has been as high as $120 and as low as $57.20 in the past year. It is currently 42.74% below its 52-week high and 20.12% above its 52-week low. According to the DCF calculator, the company currently looks overpriced by 75%.

The company's leading shareholder among the gurus is Frank Sands (Trades, Portfolio) with a stake of 0.77% of outstanding shares followed by Jeremy Grantham (Trades, Portfolio) with 0.54%. On Third position the hedge fund PRIMECAP Management (Trades, Portfolio) with 0.29% and Andreas Halvorsen (Trades, Portfolio) with 0.24%.